Trademark Overview
On Monday, October 7, 2024, a trademark application was filed for BLOSSOM LIFE SCIENCES with the United States Patent and Trademark Office. The USPTO has given the BLOSSOM LIFE SCIENCES trademark a serial number of 79412121. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, December 12, 2024. This trademark is owned by Blossom Life Sciences SAS. The BLOSSOM LIFE SCIENCES trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:
Providing online publications in the nature of an interactive database containing protocols in the life science industry.
Downloadable or recorded computer software and firmware for protocol programming in the biotech industry; downloadable or recorded computer software for artificial intelligence applications to assist scientists in defining, developing, and programming protocols; downloadable or recorded computer software for artificial intelligence applications to assist in drug discovery and innovation; laboratory instruments for automating protocol execution in the field of cellular and molecular biology and life sciences; laboratory instruments for assisting scientists and lab technicians in designing, building, testing and iterating on research and development protocols in the field of cellular and molecular biology and life sciences; laboratory instruments for executing protocols relating to diagnostics in the field of healthcare.
Providing research, design, and development services for computer software and firmware in the biotech industry; providing research, design, and development services and automation services in the biotech industry; providing Software as a Service (SaaS) services featuring software for developing and designing protocols; providing Software as a Service (SaaS) services featuring software for automating protocol execution in the field of cellular and molecular biology and life sciences; providing Software as a Service (SaaS) services featuring software for generating data in the field of cellular and molecular biology and life sciences; providing Software as a Service (SaaS) services featuring artificial intelligence applications to assist scientists in defining, developing, and programming protocols; providing Software as a Service (SaaS) services featuring artificial intelligence applications to assist in drug discovery and innovation.
